Literature DB >> 8043060

Clostridium difficile colitis.

C P Kelly1, C Pothoulakis, J T LaMont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8043060     DOI： 10.1056/NEJM199401273300406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  285 in total

1.  Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens.

Authors:  D P Fedorko; H D Engler; E M O'Shaughnessy; E C Williams; C J Reichelderfer; W I Smith
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 3.  Recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; C P Kelly
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  Surgical management of fulminant pseudomembranous colitis.

Authors:  A Boyer; G Thiery; E Pigne; A De Lassence
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

Review 5.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Probiotics and antibiotic associated diarrhoea. Lactulose is effective.

Authors:  Mark Battle; Lara Teare; Sue Law; Jamie Fulton
Journal:  BMJ       Date:  2002-10-19

Review 7.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

8.  The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B.

Authors:  M H Souza; A A Melo-Filho; M F Rocha; D M Lyerly; F Q Cunha; A A Lima; R A Ribeiro
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

9.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 10.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.